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Abstract: Severe damage to cell repair mechanisms of the limbal region can lead to many 
disorders such as vascularized conjunctivalization, keratinization, corneal scarring, and corneal 
opaciﬁ  cation, collectively described as limbal stem cell deﬁ  ciency (LSCD). Limbal stem cell 
deﬁ  ciency may occur as a result of depletion of stem cells or destruction of their stromal niche. 
In such cases, apart from conventional corneal transplantation, limbal stem cell transplantation 
would be needed to restore vision. Limbal stem cells may be replenished by autologous limbal 
transplants from the healthy fellow eye in unilateral cases, and allografts from living related 
donors or cadaveric donors in bilateral cases. The induction of iatrogenic LSCD and its sequelae 
in donor eyes have motivated researchers to cultivate sheets of limbal epithelium ex vivo, from 
small fragments of donor tissue for the purpose of ocular surface reconstruction.
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Introduction
The integrity of the self-renewing corneal epithelium relies on the existence of stem 
cells, which are located in the limbal basal layer (Sun and Green 1977). These limbal 
stem cells are supported by a unique stromal microenvironment: the stem cell niche 
(Watt and Hogan 2000). Destructive loss of limbal stem cells or dysfunction of their 
stromal niche causes what is clinically referred to as limbal stem cell deﬁ  ciency, 
characterized by conjunctivalization of the cornea, vascularization, chronic inﬂ  amma-
tion, and persistent epithelial defects (Dua et al 1994). Severe ocular surface disease 
resulting from LSCD as in chemical injury, Stevens-Johnson syndrome (SJS) and 
ocular cicatricial pemphigoid are devastating conditions that represent a major clinical 
challenge. Conventional corneal transplants alone in these conditions are destined to 
fail. Ocular surface reconstruction by means of amniotic membrane transplantation 
and limbal transplantation has been effective to some extent. More recently cultivated 
limbal stem cell transplantation, which is the focus of this review, has been shown 
to be a promising treatment modality in the management of severe limbal stem cell 
deﬁ  ciency (Pellegrini et al 1997; Koizumi et al 2001b; Sangwan et al 2006).
Limbal stem cells
Stem cells are deﬁ  ned by their capacity of unlimited or prolonged self-renewal that 
can produce at least one type of highly differentiated progeny (Grueterich et al 2003). 
The stem cells of the corneal epithelium are located in the limbal basal layer and are 
the ultimate source of corneal epithelial renewal (Sun and Green 1977). Cotsarelis 
and colleagues (1989) conﬁ  rmed the presence of a small subpopulation of slow-cy-
cling limbal basal stem cells that had a signiﬁ  cant reserve capacity and proliferative 
response to wounding.
Limbal stem cells have a long life span with a slow cell cycle with low mitotic 
activity under the normal steady state. Limbal stem cells are supported by a unique Clinical Ophthalmology 2008:2(3) 490
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stromal microenvironment called the stem cell niche, which 
consists of certain extracellular matrix components, cell 
membrane associated molecules, and cytokine dialogues 
(Watt and Hogan 2000). They may be activated on demand 
for tissue regeneration to increase their own population or 
to differentiate into transient amplifying cells (TAC), which 
are located in the corneal basal epithelium (Figure 1). On the 
contrary, TAC have a limited proliferating capacity with a 
short life span and are rapid cycling (Lehrer et al 1998).
The limbal basal epithelial cells express the keratin pair 
K5/K14, like most of the undifferentiated cells of the strati-
ﬁ  ed epithelia but are devoid of the cornea-speciﬁ  c keratin 
pair K3/K12 (Schermer et al 1986).
Limbal stem cell deﬁ  ciency
Limbal stem cells or the niche in which they reside can 
be compromised by a variety of insults leading to what is 
clinically known as limbal stem cell deﬁ  ciency (LSCD). 
LSCD is characterized by conjunctivalization of the cornea 
(conjunctival epithelial ingrowth), vascularization, chronic 
inﬂ  ammation, and poor epithelial integrity that manifests 
as irregular corneal surface, recurrent erosion, persistent 
epithelial defects and ﬁ  brous ingrowth (Figure 2) (Anderson 
et al 2001).
Limbal stem-cell deﬁ  ciency can be primary, related to an 
insufﬁ  cient stromal microenvironment to support stem cell 
function, such as aniridia, congenital erythrokerato-dermia, 
keratitis associated with multiple endocrine deﬁ  ciencies, 
neurotrophic (neural and ischaemic) keratopathy and chronic 
limbitis; or secondary (more common) related to external 
factors that destroy limbal stem cells such as chemical 
(most common) or thermal injuries, SJS, ocular cicatricial 
pemphigoid (OCP), multiple surgeries or cryotherapies, 
contact lens wear, or extensive microbial infection (Potten 
and Morris 1988; Tseng 1989; Kruse 1994; Pﬁ  ster 1994; Dua 
1995). Corneal stem-cell deﬁ  ciency can be diffuse (total) 
or sectoral (partial) (Figure 3). In the latter case conjuncti-
valisation of the corneal epithelium affects only part of the 
corneal surface. In some patients, limbal deﬁ  ciency may 
be subclinical at the time of the insult, and may eventually 
progress to an overt stage of limbal deﬁ  ciency as the stem 
cell population depletes further, over time (Dua et al 1994). 
If the conjunctival stem cells (presumed to be in the fornices) 
are also depleted, which is rare because of the larger area 
Conjunctiva LIMBUS
Peripheral Central
TDC
TDC
TCA
Proliferative compartment
Suprabasal Cell
SC
Goblet Cells
Basal Cells
PMC
PMC
Differentiative
Compartment
CORNEA
Figure 1 Schematic diagram explaining the steps involved in proliferation and differentiation of limbal stem cells.
Abbreviations: PMC, post-mitotic cells; SC, stem cells; TAC, transient amplifying cells; TDC, Terminally differentiated cells.Clinical Ophthalmology 2008:2(3) 491
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they occupy the ocular surface is eventually keratinised, 
which sometimes may be seen at the end stage of OCP or 
SJS (Coster et al 1995).
Corneal stem cell deficiency can be best confirmed 
histologically by the use of impression cytology, which can 
detect goblet cells containing conjunctival epithelium on 
the corneal surface (Sangwan 2001). Immunohisto-chemi-
cally, the absence of keratin CK3, and the presence of mucin 
in goblet cells, has been shown by monoclonal antibodies 
(Kenyon et al 1990). Diagnosis of limbal stem cell deﬁ  ciency 
is crucial because patients with this abnormality generally 
are poor candidates for conventional corneal transplantation. 
Lamellar or penetrating keratoplasty provides only a tempo-
rary replacement of the host’s corneal epithelium because the 
grafted epithelial cells have a limited proliferative capacity 
and lifespan (Dua et al 2000).
Management of LSCD
Asymptomatic patients with partial and peripheral conjuncti-
valisation of the corneal surface may not require intervention. 
Corneal and conjunctival epithelial cell phenotypes have 
been known to co-exist on the corneal surface for prolonged 
periods without signiﬁ  cant extension of the conjunctivalised 
area or any transdifferentiation of conjunctival epithelium 
into cells of corneal phenotype (Coster et al 1995; Dua 1995). 
If the visual axis or most of the corneal surface is covered 
with conjunctiva-like epithelium, mechanical debridement 
of conjunctival epithelium can allow adequate corneal 
epithelial healing to occur from the remaining intact limbal 
epithelium (Coster et al 1995; Dua 1995). Scraping is done 
with a surgical blade under topical anesthesia at the slit lamp. 
Any tendency of conjunctiva-like epithelium to re-encroach 
on to corneal surface is prevented by re-scraping (Coster 
et al 1995). This procedure can be employed to improve 
visual function and reduce symptoms even when as little 
as two clock hours of normal limbus and peripheral cornea 
remain. When visual improvement is the aim of treatment, 
the objective should be to achieve normal corneal epithelial 
cover over the visual axis. An attempt to achieve normal 
epithelial cover for the entire cornea, when only two clock 
hours or less of limbus are surviving, may stretch the capac-
ity of the remaining limbus and could eventually lead to 
epithelial breakdown.
Mechanical debridement of conjunctiva-like epithelium 
and encouraging the denuded area to be resurfaced with cor-
neal epithelial cells is a valid, simple and effective alternative 
to limbal transplantation in patients with partial limbal stem 
cell deﬁ  ciency (see below).
Figure 2 Slit lamp photo showing causes of limbal stem cell deﬁ  ciency (LSCD). A: Corneal pannus due to vernal keratoconjunctivitis (VKC). B: Dysfunction of limbal stem 
cell in a patient with VKC. C: Total stem cell deﬁ  ciency with conjunctivalisation and multiple symblephara in a patient with chemical injury. D: Peripheral corneal destruction 
due to Mooren’s ulcer which leads to limbal stem cell deﬁ  ciency over a period of time.Clinical Ophthalmology 2008:2(3) 492
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Mechanical debridement can also be used to prevent 
migration of conjunctival epithelium on to the cornea in 
acute situations, with partial corneal and limbal epithelial 
loss. Close observation of patients with thermal, chemical 
or mechanical epithelial loss involving the limbus, will 
allow one to detect the advancing conjunctival epithelial 
sheet and prevent it from extending on to and beyond the 
limbus (Coster et al 1995). Tseng and colleagues (1998) 
have successfully used amniotic membrane transplanta-
tion (AMT) and mechanical debridement and advocate its 
use to treat patients with partial stem cell deﬁ  ciency. Their 
study showed that with partial or focal limbal stem cell 
deﬁ  ciency, AMT improves both the corneal surface and 
the vision (Tseng et al 1998).
In patients with total limbal stem cell deﬁ  ciency, limbal 
auto- or allo-transplantation is indicated for corneal surface 
reconstruction. This may be combined with or followed by 
keratoplasty. Several modiﬁ  cations have been described of 
the technique proposed by Kenyon and Tseng (1989). All 
these procedures aim to transplant a new source of epithelium 
for a diseased ocular surface and the removal of the host’s 
altered corneal epithelium and pannus. After successful 
transplantation, the host’s cornea (or grafted cornea) will be 
permanently covered by epithelium from the donor limbus.
Although all techniques used in stem cell transplantation 
are in principle similar, the source of donor stem cells can 
vary. Donor tissue can be obtained from the fellow eye (lim-
bal autograft) in cases of unilateral disease, or from a living 
related donor (usually gives a better tissue match), or from a 
cadaver donor (limbal allograft) when both eyes are affected. 
Limbal transplantation procedures also vary depending on the 
carrier tissue used for the transfer of the limbal stem cells. 
Carrier tissue is needed in limbal transplants because it is not 
possible to transfer limbal stem cells alone. Limbal transplant 
procedures have used either conjunctiva (conjunctival limbal 
graft) or cornea (keratolimbal graft) as a carrier tissue for 
limbal stem cells (Dua et al 2000). Tseng and colleagues 
(1998) used AMT associated with limbal transplantation 
in cases with total stem cell deﬁ  ciency. In the past decade 
some authors have used conjunctival transplantation to treat 
corneal stem cell deﬁ  ciency. This practice was supported by 
the belief that conjunctival epithelium “transdifferentiates” 
into cornea-like epithelium. However, conjunctival epithelial 
transdifferentiation (that is, acquisition of morphologic, bio-
chemical, and physiologic transplantation properties of cor-
neal epithelium) does not occur in humans and conjunctival 
transplantation to reconstruct the corneal surface in stem cell 
deﬁ  ciency is inferior to limbal transplantation (Tseng et al 
1984). Conjunctival transplantation is, however, useful in 
other conditions, for example, to reconstruct the conjunctival 
surface in cases of symblepharon and to treat primary and 
recurrent pterygia. Keratoepithelioplasty was proposed by 
Thoft as another alternative to reconstruct the ocular surface 
in patients with conjunctivalisation of the corneal surface 
(Dua et al 2000). In this technique, lenticules of peripheral 
corneal epithelium with superﬁ  cial stroma, were grafted. 
A few years later the same author modiﬁ  ed the technique to 
include limbal tissue, acknowledging the importance of stem 
cell transplantation in these conditions (Dua et al 2000).
Successful limbal transplantation can achieve rapid sur-
face healing, stable ocular surface without recurrent erosions 
or persistent epithelial defects, regression of corneal vascu-
larisation and restoration of a smooth and optically improved 
ocular surface, resulting in improved visual acuity and, prob-
ably, increased success for subsequent keratoplasty.
Figure 3 Slit lamp photo of total (A) and partial (B) limbal stem cell deﬁ  ciency due 
to chemical injury.Clinical Ophthalmology 2008:2(3) 493
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In patients with unilateral total stem cell deﬁ  ciency a 
limbal autograft transplantation is recommended. Partial 
removal of the limbus from the fellow eye is believed to be 
relatively safe, although some cases may have compromised 
donor surface after partial removal of the limbal zone. The 
risk of epithelial problems in the donor eye is low when less 
than four to six clock hours of limbal tissue and a moderate 
amount of conjunctiva are removed.
When patients have bilateral total ocular surface dis-
ease, allograft transplantation becomes necessary. If living 
relatives are potential donors, an HLA-matched tissue is 
preferred. When cadaver donor tissue is used, “fresh” eyes 
are preferred because the success of the procedure depends 
on the transplantation of healthy limbal stem cells. Whole 
eyes are convenient because they provide better stabilisation 
during dissection of the limbal sclerocorneal rim.
In limbal allografts the surface disorder can recur if there 
is immunological destruction of the transplanted limbal 
stem cells. A high rate of immune reactions can be expected 
because of the high immunogenic stimulus of the limbal 
transplant, related to the relative abundance of Langerhans 
cells and HLA-DR antigens. They play an important role in 
the afferent arm of allograft rejection, and effective immu-
nosuppression is considered essential for at least 12 months 
after surgery when non-HLA matched limbal allografts are 
used. In some instances permanent systemic immunosup-
pression may be needed. Oral cyclosporine A is the most 
commonly used agent (Tseng et al 1995). In addition to oral 
cyclosporine, Tsubota et al also used topical cyclosporine 
(0.05%) and high dose intravenous dexamethasone in their 
patients (Tsubota et al 1995). The use of FK 506 (tacrolimus; 
Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan), a new 
immunosuppressive agent from the fermentation broth of 
Streptomyces tsukabaensis, for immunosuppression in limbal 
or corneal allografts has been recently reported by Dua and 
Blanco (1999). Limbal rejection can be suspected with the 
development of inﬂ  ammation and/ or acute or chronic severe 
surface abnormalities. Daya and colleagues (1999) and Dua 
and Blanco (1999) have reported the clinical features of 
limbal allograft rejection. In their study, the clinical features 
of limbal allograft rejection varied according to the presenta-
tion, whether acute or chronic, of the rejection episode. Acute 
rejection was associated with intense sector injection at the 
limbus, edema, and inﬁ  ltration of the lenticule, punctate 
keratopathy and epithelial defects. In low-grade rejection 
there was mild diffuse or perilimbal injection, elevated per-
ilimbal area, punctate epithelial keratopathy and epithelial 
irregularity (Daya et al 1999).
Cultivated limbal stem cell 
transplantation
Kenyon and Tseng (1989) proposed the procedure of 
conjunctival limbal autograft taken from the healthy fellow 
eye in patients with unilateral total LSCD. The procedure 
involves the transplantation of two large free grafts, each 
spanning from 5–7 mm in limbal arc length, removed from 
a healthy eye (Kenyon and Tseng 1989). Reported complica-
tions in donor eyes have included localized haze in a patient 
with contact lens-induced keratopathy, pseudopterygium, 
ﬁ  lamentary keratitis, microperforation during surgery, ab-
normal epithelium, and corneal depression. Such a concern 
preludes one from obtaining two such grafts from a donor eye 
with undiagnosed partial LSCD. Ex vivo expansion of limbal 
epithelial stem cells has been developed to circumvent po-
tential complications related to conjunctival limbal autograft 
transplantation. The aim of differentiating these epithelial 
stem cells ex vivo is to help develop an equivalent of the 
human cornea using tissue culture techniques. Transplanta-
tion of cultivated limbal epithelium is currently the most 
successful alternative to surface reconstruction in patients 
with unilateral disease and offers a therapeutic chance to 
patients with severe bilateral disease (Pellegrini et al 1997; 
Koizumi et al 2001b; Sangwan et al 2006).
The various protocols for cultivation of limbal epithe-
lium differ in the use of intact versus epithelially denuded 
amniotic membrane, suspension of epithelial cells rather 
than explants, co-cultivation of 3T3 ﬁ  broblast feeder layers, 
and air-lifting prior to transplantation. Currently no study 
has been conducted to compare these cultivation variables 
in order to determine which one is vital in achieving effec-
tive expansion of limbal epithelial progenitor cells (Schwab 
1999; Grueterich and Tseng 2002a; Grueterich et al 2002b, 
2002c; Koizumi et al 2001a, 2002; Meller et al 2002; Espana 
et al 2003).
Pellegrini and colleagues (1997) ﬁ  rst reported successful 
reconstruction of the ocular surface in LSCD. A 1 mm2 biopsy 
sample from the healthy fellow eye was treated with trypsin 
for 3 hrs. The cells were plated on lethally irradiated 3T3-J2 
cells and cultured in 5% carbon dioxide in Dulbecco-Vogt 
Eagle’s and Ham’s F12 media. Grafts were prepared from 
conﬂ  uent secondary cultures which were released from the 
plastic dish by neutral protease Dispase II and either mounted 
on a petrolatum gauze or a soft contact lens (Pellegrini et al 
1997).
The next advancement in this technique was the use of 
human amniotic membrane as a substrate for in vitro epithelial 
cell culture. Koizumi and colleagues (2000a) ﬁ  rst cultivated Clinical Ophthalmology 2008:2(3) 494
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rabbit limbal epithelium on human amniotic membrane 
(HAM) in vitro and then, after transplantation onto rabbit 
ocular surface, conﬁ  rmed the viability of the transplanted 
cultivated epithelium in vivo. Subsequently they showed that 
denuded HAM was better than intact cellular HAM for corneal 
epithelial cell culture (Koizumi et al 2000b). They adopted 
the culture system using epithelially denuded HAM with an 
underlying layer of lethally irradiated mouse 3T3 ﬁ  broblasts. 
Their results showed that the expanded epithelium resembled 
a corneal phenotype with respect to the expression of K3 
keratin (Koizumi et al 2001a, 2001b).
Grueterich and colleagues (2002b) demonstrated that 
culturing limbal explants on an intact amniotic membrane 
without the use of a 3T3 feeder layer resulted in a limbal 
epithelial phenotype.
Koizumi and colleagues (2002) demonstrated that both 
cell suspension and explant culture methods produced a 
healthy epithelial cell layer, with cells from the former being 
morphologically more superior.
Currently most investigators prefer the explant culture 
technique (Tsai et al 2000; Grueterich et al 2002c; Koizumi 
et al 2000c, 2001b; Shimazaki et al 2002). The beneﬁ  ts of 
using explants are that they are easy to prepare and there 
is no danger of damaging the corneal epithelium through 
enzyme treatment.
The general principles of culturing the cells by explant 
culture technique involve the following steps: harvesting the 
limbal tissue (from the contralateral healthy eye in case of a 
unilateral LSCD, or from donor corneas for bilateral LSCD); 
selecting the appropriate carrier: a sheet of multi-layered 
epithelium, human amniotic membrane, collagen shields, 
or contact lens; preparation of human corneal epithelial 
medium; and explant cultures (Sangwan 2001).
Conﬁ  rmation of growth can be done by various methods 
including-direct observation, whole mount stained prepara-
tion, histopathology, immunohistochemistry, thymidine 
incorporation and by ﬂ  ow cytometry using markers for cell 
cycle. Details of a few of the procedures can be found in 
an earlier publication (Vemuganti and Balasubramanian 
2002).
Although a number of investigators have included vari-
ous reconstruction techniques through the use of autogenous 
conjunctiva, mucous membrane grafts, collagen lattices, 
synthetic implants, and cell-suspension cultures, the most 
widely accepted universal substratum for explant cultures 
is the HAM (Grueterich et al 2003). It was recognized and 
successfully reintroduced by Kim and Tseng (1995) for cor-
neal surface reconstruction in rabbits. Amniotic membrane 
is the innermost layer of the fetal or placental membrane 
and consists of an epithelial monolayer, a thick basement 
membrane, and an avascular stroma. Preserved HAM can 
be used a biological substrate without viable and active 
proliferative cells. It is thus nonimmunogenic and therefore 
does not require immunosupression when used as a graft for 
transplantation.
Amniotic membrane serving as stem cell 
niche
The role of the devitalized epithelium is not yet fully un-
derstood. It has been shown that native, intact amniotic 
membrane (AM) epithelium contains higher levels of epi-
dermal growth factor, keratinocyte growth factor, hepatocyte 
growth factor, and basic ﬁ  broblast growth factor compared 
with epithelially denuded AM. However, Koizumi and col-
leagues (2000b) indicated that denuded AM promotes better 
corneal epithelial cell colonization than intact AM does 
and that corneal cells from the limbal epithelium colonize 
denuded AM more readily than epithelial cells from the 
central cornea. Corneal cells colonize intact HAM much 
less quickly than denuded amnion. Moreover, migrating 
limbal SC on denuded HAM have a smooth, uniform lead-
ing edge compared with the irregular raised edges of sheets 
grown on intact HAM. Morphologic observations further 
strengthen the support for epithelium grown on denuded 
HAM. The basal cells grown on bare amniotic membrane 
are nicely columnar, and the more superﬁ  cial cells seem 
fairly well differentiated into wing cells and surface cells. 
In contrast slowly growing epithelial cells on intact HAM 
do not take the appearance of normal corneal epithelium. 
However, expanded epithelium from limbal explants on 
intact AM adopts a limbal epithelial phenotype whereas that 
expanded on epithelially denuded HAM reveals a corneal 
epithelial phenotype (Grueterich et al 2002b). Wei and 
colleagues (2007) have further demonstrated that during 
ex vivo expansion on intact HAM some limbal epithelial 
progenitor cells migrate onto intact AM whereas some also 
invade the limbal stroma, very likely undergoing epithelial-
mesenchymal transition. The HAM’s basement membrane 
contains type IV collagen, ln-1, Ln-5, ﬁ  bronectin, and col-
lagen VII. The collagen IV subchain α2, is identical to that 
of the conjunctival BM. Ln play an important role in corneal 
epithelial cell adhesion. Overall the basement membrane 
facilitates migration of epithelial cells, reinforces adhesion 
of basal epithelial cells, promotes epithelial differentiation, 
and prevents epithelial apoptosis, that is, programmed cell 
death (Lee et al 2000).Clinical Ophthalmology 2008:2(3) 495
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The AM stroma also contains a number of growth factors, 
various antiangiogenic and anti-inﬂ  ammatory proteins, and 
natural inhibitors to various proteases (Sato et al 1998). In 
view of all of the above-mentioned properties of the AM, 
there is little doubt that it provides an ideal stromal niche 
desirable for stem cell expansion.
Limbal cell culture: Explant culture tech-
nique
Many investigators have adopted the explant culture tech-
nique with variations in substrate, media, feeder cells, and 
airlifting (Koizumi et al 2000c, 2001b; Tsai et al 2000; 
Grueterich et al 2002c; Shimazaki et al 2002). To elaborately 
describe the details of each protocol is beyond the scope of 
this article. Therefore the modiﬁ  cations that the authors have 
incorporated in their procedure have been described with 
respect to reports from previous investigators.
Limbal biopsy
After satisfying the Institutional Review Board, informed 
consent is obtained from the patients or guardians. Limbal 
biopsy is performed on the healthy contralateral eye or a 
healthy area of the ipsilateral eye. The procedure includes 
careful dissection of a 1 × 2 mm2 piece of limbal epithelium 
with 1 mm into clear corneal stromal tissue at the limbus 
under strict aseptic conditions. A conjunctival peritomy is 
made 2–3 mm from the limbus and dissection of the con-
junctiva is carried forwards 1 mm beyond the limbal arcade. 
The harvested tissue should exclude the Tenon’s capsule and 
should include the palisades of Vogt. Post-operatively topi-
cal antibiotic is used four times day for two weeks. Topical 
steroids are used in tapering doses for 4 to 6 weeks or until 
complete healing of donor site.
AMG procurement, processing, 
and preservation
Amniotic membrane is obtained from prospective donors 
undergoing caesarean section, who are negative for com-
municable diseases including HIV, hepatitis, and syphilis. 
Different protocols exist for the processing and storage (Kim 
and Tseng 1995; Shimazaki et al 1997). According to Kim 
and Tseng (1995), the amnion is separated from the chorion 
by blunt dissection, and washed with balanced salt solution 
containing a cocktail of antibiotics (50 μg/ml penicillin, 
50 μg/ml streptomycin, 100 μg/ml of neomycin, as well as 
2.5 μg/ml of amphotericin B) under sterile conditions. The 
separated membranes are cut in different sizes (3 × 4 mm2) 
and placed on nitrocellulose paper strips with the epithelial 
side up. Dulbecco Modiﬁ  ed Eagles’ Medium/glycerol (1:1) is 
used for cryopreservation and the tissues are frozen at −80 °C 
degrees until further use (Kruse et al 2000). Just before use, 
the amniotic membrane is thawed at 37 °C for 30 min. and 
placed on a sterile cut glass slide. The amniotic epithelium 
is removed by digestion with 0.1% trypsin-EDTA at 37 °C, 
followed by scraping.
Under sterile conditions, the membrane is inspected 
under the microscope for complete removal of cells. The 
de-epithelized membranes are then spread on a glass slide 
(used as culture inserts) in a Petri plate tucking the edges for 
a uniform surface (Koizumi et al 2000c, 2001b; Sangwan 
et al 2006; Shimazaki et al 2002).
Tsai and colleagues (2000) and Grueterich and colleagues 
(2002c) have cultivated explants on intact AM.
Human corneal epithelial cell growth 
medium
We use a modiﬁ  ed human corneal epithelial cell (HCE) cul-
ture medium, prepared using 9.7 g/l Modiﬁ  ed Eagle Medium 
(MEM) with addition of 16.2 g/l Ham F12 serum, 0.01mg/l 
epidermal growth factor, 0.25 mg/l insulin, 0.1 mg/l cholera 
toxin, and hydrocortisone.
The medium is ﬁ  ltered with 0.22 mm membrane ﬁ  lters 
using a vacuum pump. This is supplemented with autologous 
serum or 10% fetal calf serum (FCS) at the time of use.
Explant culture technique
The authors follow a submerged explant culture system 
without the use of any feeder cell layer or airlifting (Tsai 
et al 2000; Grueterich et al 2002c; Shimazaki et al 2002; 
Sangwan et al 2006). Koizumi and colleagues (2000c, 2001b) 
have used 3T3 feeder cells along with airlifting for epithelial 
stratiﬁ  cation. Limbal tissue procured by biopsy is shredded 
into 4–6 fragments, and placed on the de-epithelized mem-
branes separately and allowed to settle down by overnight 
incubation at 37 °C with 5% CO2 and 95% air (Figure 4).
The medium is changed on alternate days for 10–14 days 
with daily monitoring of cell growth under phase-contrast 
microscope. In four days polygonal cells could be seen grow-
ing from the edges of the explant.
Whole mount preparation
After conﬁ  rming conﬂ  uent growth of a monolayer from the 
explanted tissue over 1–2 weeks, the growth is terminated 
by replacing the medium with 10% buffered formalin. The 
whole mount preparation, stained with hematoxylin and 
eosin, could be seen as bluish rings of stained areas around Clinical Ophthalmology 2008:2(3) 496
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the original explanted tissue. When observed under the mi-
croscope, the cultured cells appear as a monolayer of large 
polygonal cells with an epithelial appearance. The membrane 
with the cultured limbal tissue and the cultured cells is ﬁ  xed 
in formalin and processed for routine histopathology with 
parafﬁ  n embedding. The sections are cut at 4–5 cm and after 
deparafﬁ  nization, stained with hematoxylin and eosin stain 
and periodic acid-Schiffs stain. In contrast to the cuboidal epi-
thelium of the normal amniotic membrane the cultured cells 
form an epithelium of 1–2 layered cells over the amniotic 
membrane. Immunostaining on the formalin-ﬁ  xed, parafﬁ  n-
embedded sections can be done using prediluted antibodies 
to cytokeratin 3 (K3) and cytokeratin 19 (K19) from DAKO 
(Copenhagen, Denmark) to conﬁ  rm the corneal phenotype of 
the cultured cells (Figure 5) (Vemuganti et al 2004).
Cell suspension culture of limbal 
epithelial cells
Preparation of AM and 3T3 ﬁ  broblast cells
As described in detail in previous reports, AMs obtained 
at the time of caesarean section were washed with sterile 
phosphate-buffered solution (PBS) containing antibiotics 
and stored at –80 °C in Dulbecco’s modiﬁ  ed Eagle medium 
and glycerol at a ratio of 1:1. Immediately before use the 
Figure 4 Schematic diagram showing the steps in cultivation of limbal epithelial stem cells. A: Technique of limbal biopsy (See text for details). B: Processing of tissue in the 
laboratory and making the explant culture. C: Petridish, glass slide (white) with de-epithelialized human amniotic membrane with explants (red dots) with growing cells around 
it (blue dots). D: Monolayer of cells (10–14 days old) under phase contrast microscope.Clinical Ophthalmology 2008:2(3) 497
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membrane was thawed, washed 3 times with sterile PBS, and 
cut into pieces of approximately 2.5 cm2 and denuded.
Conﬂ  uent 3T3 ﬁ  broblasts were inactivated by incubation 
in 4 μg/ml mitomycin C (MMC) for 2 hours at 37 °C under 
5% CO2, and then trypsinized and plated onto plastic dishes 
(Pellegrini et al 1997; Schwab 1999; Koizumi et al 2000a; 
Schwab et al 2000).
Cell suspension
The whole limbal ring was cut into two to three peices, 
and these were incubated at 37 °C for one hour with 1.2 IU 
dispase. The corneal limbal epithelium including the limbal 
stem cells were suspended in 3 ml medium, seeded onto 
three pieces of denuded AM spread on the bottom of the 
culture inserts, and co-cultured with MMC-inactivated 3T3 
ﬁ  broblasts. The culture was submerged in the medium for 
2 weeks and then exposed to air by lowering the medium 
level (airlifting) for 2 weeks to promote corneal epithelial 
differentiation. The culture medium used was Dulbecco’s 
modiﬁ  ed Eagle’s medium and Ham’s F12 (1:1 mixture) 
(Koizumi et al 2002).
Surgical technique
The surgery is performed 10–14 days after the limbal biopsy. 
Following strict aseptic precautions, under local or general 
anesthesia, a drop of 1:1000 epinephrine is instilled into the 
conjunctival cul de sac to ensure hemostasis. The ﬁ  brovas-
cular pannus is dissected off the corneal surface starting 2–3 
mm beyond the limbus using a conjunctival spring scissors 
until the limbus and beyond. A plane of dissection is usually 
noted in patients who have undergone previous ocular surface 
reconstruction with AM, facilitating the excision.
Symblepharon release is carried out at the same time and 
AM is used to reconstruct the ocular surface. Fornix recon-
struction is also performed where appropriate.
The AM, with its monolayer of cultured limbal epithelial 
cells, is then transferred to the ocular surface and anchored in 
place at the limbus with interrupted 10–0 monoﬁ  lament ny-
lon sutures placed circumferentially. The knots are trimmed 
and buried. The peripheral skirt of the AM is anchored to 
the conjunctiva with 8–0 vicryl sutures. Subconjunctival 
dexamethasone is given at the end of surgery. Some authors 
recommend mitomycin C subconjunctivally to prevent re-
currence of symblepharon and a bandage contact lens may 
be inserted.
In some patients with chemical injury, corneal scarring, 
and who may have undergone prior attempts at surface 
reconstruction, difﬁ  culties may be encountered in suturing 
the donor corneal tissue to the thin recipient bed. In such 
cases, cultured LSC transplantation may be combined with 
either a lamellar keratoplasty or deep anterior lamellar 
keratoplasty. Preoperative anterior segment interferometry 
or intraoperative pachymetry after pannus resection may 
indicate the residual stromal thickness and aid the decision 
for lamellar keratoplasty (LK) or deep anterior lamellar 
keratoplasty (DALK).
In cases with anterior to mid stromal scarring and thin-
ning, a lamellar keratoplasty may be done using a crescent 
blade or an automated keratome. The lamellar donor cor-
neal tissue is sutured to the recipient bed with interrupted 
Figure 5 Photomicrograph of cultivated limbal epithelial cells stained for keratin 3 and 
12 (A) showing the corneal epithelial phenotype and basement membrane (green) 
secreted by the growing cells (B).Clinical Ophthalmology 2008:2(3) 498
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10–0 monoﬁ  lament nylon sutures and the AM with cultivated 
limbal epithelium is placed on the entire de-epithelized 
surface.
Alternatively, a deep anterior lamellar keratoplasty may 
be performed to provide a smooth interface.
Penetrating keratoplasty (PK) 
after limbal stem cell 
transplantation (LSCT)
A penetrating keratoplasty is usually planned 3 months 
post operatively once the ocular surface has stabilised for 
visual loss related to corneal scarring in the visual axis. The 
recipient cornea is trephined in the centre with a disposable 
trephine and a donor tissue 0.5 mm larger is anchored to the 
recipient bed with interrupted 10–0 monoﬁ  lament sutures. 
A lensectomy, vitrectomy, synechiolysis, and/or intraocular 
lens implantation may be carried out if deemed necessary. 
In the immediate post-operative period, it is imperative to 
watch for signs of epithelial breakdown and allograft rejec-
tion. It is worthwhile to perform a primary tarsorrhaphy in 
such cases.
Eleven of the 19 corneal grafts were successful with a 
mean follow up of 17.4 months. It is important to note that all 
these grafts met the criterion for of high risk for corneal graft 
rejection and none of them were on systemic immunosup-
pression. The authors attribute these results to a multistaged 
approach wherein the PK is performed three months post 
CLSCT as it not only ensures a stable ocular surface but also 
decreases the risk of corneal graft rejection by controlling 
inﬂ  ammation. A second hypothesis is decreased sensitization 
by decreasing antigen presentation as the cultivated epithe-
lium is devoid of dendritic cells. The early outcome of PK 
following cultivated limbal epithelial transplantation is very 
promising with 87% of grafts remaining clear at mean fol-
low up of 8.3 months post PK and 25% developing corneal 
allograft rejection (Sangwan et al 2005).
Outcome of cultivated LSCT
Pelligrini and colleagues (1997) were the ﬁ  rst to show that 
cultured limbal cells generated cohesive sheets of authentic 
corneal epithelium, and the autologous cultured corneal 
epithelium restored the corneal surface of two patients with 
complete loss of the corneal-limbal epithelium. Long-term 
follow-up at more than 2 years showed the stability of re-
generated corneal epithelium and the striking improvement 
in patient’s comfort and visual acuity.
Schwab and colleagues (2000) reported a successful 
outcome, deﬁ  ned as restoration or improvement of vision, 
along with maintenance of corneal re-epithelialization and 
absence or recurrence of surface disease, obtained in 6 of 
the 10 patients with autologous procedures and in all 4 of 
the allogenic procedures (Tsai et al 2000). Follow up ranged 
16–19 months with a mean of 13 months. They concluded 
that both amniotic membrane and corneal epithelial stem 
cells present within the bio-engineered graft were necessary 
for successful repair.
Tsai and colleagues (2000) documented complete 
reepithelialization of the corneal surface occurred within 
two to four days of transplantation in all six eyes receiving 
transplants. By one month, the ocular surface was covered 
with corneal epithelium, and the clarity of the cornea was 
improved. In ﬁ  ve of the six eyes receiving transplants (83%), 
the mean visual acuity improved from 20/112 to 20/45. In 
one patient with a chemical burn who had total opaciﬁ  ca-
tion of the cornea, the acuity improved from the ability to 
count ﬁ  ngers at 40 cm to 20/200. No patient had recurrent 
neovascularization or inﬂ  ammation in the transplanted area 
during the follow-up period.
Thirteen eyes of 11 patients were studied by Koizumi 
and colleagues (2001a). These consisted of ﬁ  ve eyes with 
acute SJS, two with chronic SJS, one with an acute chemi-
cal injury, two with chronic chemical injuries, two with 
ocular cicatricial pemphigoid, and one with drug-induced 
pseudopemphigoid. All of these eyes had total stem cell 
deﬁ  ciencies. Corneal limbal epithelium from donor corneas 
was cultivated for 4 weeks on a denuded AM carrier, with 
3T3 ﬁ  broblast coculture and air lifting. The cultivated 
corneal epithelium showed four to ﬁ  ve layers of stratiﬁ  ca-
tion and was well differentiated. After conjunctival tissue 
removal from the cornea up to 3 mm outside the limbus and 
subconjunctival tissue treatment with 0.04% mitomycin 
C, cultivated allocorneal epithelium, including the AM 
carrier, was transplanted onto the corneal surface up to 
the limbus. Lamellar keratoplasty, using preserved donor 
graft without epithelium, was performed simultaneously 
for ﬁ  ve chronic-phase patients showing corneal stromal 
scarring. Systemic immunosuppression was used to pre-
vent allograft rejection. In all 13 eyes, the entire corneal 
surface, on which cultivated allocorneal epithelium had 
been placed, was free from epithelial defects 48 hours after 
surgery, indicating complete survival of the transplanted 
corneal epithelium. Visual acuity improved in all eyes after 
surgery, and 10 of the 13 eyes were restored to good vision 
(post-operative visual acuity improved two or more lines) 
6 months after the operation. During the follow-up period 
(mean +/− standard deviation, 11.2 +/− 1.3 months), the Clinical Ophthalmology 2008:2(3) 499
Cultivated limbal stem cell transplantation
corneal surfaces were clear, although three eyes experi-
enced epithelial rejection.
Sangwan and colleagues (2006) have reported the clini-
cal outcome of autologous CLSCT in the largest series of 
patients with LSCD. The success of the procedure was de-
ﬁ  ned by a stable ocular surface and subjective improvement 
in the symptoms of the patient with a minimum follow up 
of 6 weeks (Figure 6). The stability of the ocular surface 
was assessed clinically, based on absence of recurrent 
breakdown of the corenal epithelium, increased permeability 
to ﬂ  uorescein, or conjunctivalization. Eighty-eight eyes of 
86 patients with LSCD underwent autologous cultivated 
limbal epithelium transplantation, with a mean follow-up of 
18.3 months. The etiology of LSCD was alkali burns in 64% 
patients. Sixty-one eyes had total LSCD (Figures 7A, 7B). 
Thirty-two of the 88 eyes had undergone amniotic membrane 
transplantation and 10 eyes had previously undergone lim-
bal transplantation with unfavorable outcome. Nineteen 
eyes underwent penetrating keratoplasty, of which 11 
grafts survived at the ﬁ  nal follow-up (Figures 8A, 8B, 
8C, 8D). Finally, 57 eyes (73.1%, 95% CI: 63.3–82.9) had 
a successful outcome with a stable ocular surface without 
conjunctivalization, 21 eyes (26.9%, 95% CI: 17.1–36.7) 
were considered failures and 10 patients were lost to follow-
up. They propose a novel technique of submerged explant 
culture wherein denuded HAM is used as a substrate and 
Figure 6 Slit lamp photograph of a patient with total limbal stem cell deﬁ  ciency (A) with multiple symblephara following acid injury. (B) One year after autologus culti-
vated limbal stem cell transplantation shows clear central cornea and no recurrence of symblephara and a stable ocular surface.Clinical Ophthalmology 2008:2(3) 500
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human corneal epithelial medium for ex vivo cultivation. 
The 3T3 ﬁ  broblast feeder layer or air lifting as described by 
other researchers is not used. Lastly, a conﬂ  uent monolayer 
is transplanted rather than awaiting in vitro stratiﬁ  cation.
Conclusion
The transplantation of cultivated limbal stem cells is a 
promising new alternative for ocular surface reconstruc-
tion in patients with LSCD. The procedure signiﬁ  cantly 
minimizes the risk of iatrogenic LSCD in the donor eye. 
The results of autologous cultivated limbal stem cell trans-
plants are particularly encouraging and allows for banking 
of the patient’s cells for repeat procedures. Although much 
progress has been achieved with constant modiﬁ  cations to 
the technique of cultivation and transplantation, there is 
much to be learnt before a successful bioengineered corneal 
tissue replacement is conceived for this challenging group 
of patients.
Figure 7 A. Slit lamp photograph of a patient with total limbal stem cell deﬁ  ciency with extensive symblephara following alkali injury. B. One year after autologus culti-
vated limbal stem cell transplantation shows clear central cornea and no recurrence of symblephara and a stable ocular surface.Clinical Ophthalmology 2008:2(3) 501
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Figure 8 A. Slit lamp photograph of a patient with total limbal stem cell deﬁ  ciency following alkali injury. B. Slit lamp photograph of the cornea showing a persistent scar 
with stable ocular surface, a year after cultivated LSCT. C. Slit lamp photograph at 6 months after penetrating keratoplasty. D. Photomicrograph of the hematoxylin and 
eosin-stained section of the excised corneal button showing stratiﬁ  ed corneal epithelium subsequent to cultivated LSCT.
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